SCHEMBL8083369

SCHEMBL8083369

CC(C)S(=O)(=O)NC(=O)Nc1ccc(F)c(F)c1.[NaH]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.59
KMT2A Q03164 5/20 0.59
IDH1 O75874 1/20 0.47
HTR2B P41595 1/20 0.46
ALDH1A1 P00352 1/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
KCNJ6 P48051 1/20 0.44
KCNJ5 P48544 1/20 0.44
KCNJ3 P48549 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
LMNA P02545 2/20 0.44
NAMPT P43490 1/20 0.44
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 2/20 0.41
RECQL P46063 1/20 0.41
SLC2A1 P11166 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8097749 0.87 LMNA (0.60) MEN1KMT2AIDH1ALDH1A1NPC1
SCHEMBL8094995 0.86 LMNA (0.61) MEN1KMT2AIDH1ALDH1A1NPC1
SCHEMBL8091318 0.83 TP53 (0.56) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL8083304 0.80 ALDH1A1 (0.54) MEN1KMT2AIDH1ALDH1A1NPC1
SCHEMBL8091346 0.78 ALDH1A1 (0.56) MEN1KMT2AIDH1ALDH1A1NPC1
SCHEMBL8083234 0.78 EPHX1 (0.62) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL8095025 0.77 FPR2 (0.55) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL10116618 0.76 NPC1 (0.58) MEN1KMT2AHTR2BNPC1RAB9A
SCHEMBL8083324 0.75 FPR2 (0.56) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL8663690 0.74 ACP1 (0.62) KMT2AALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed